{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:18:46Z","timestamp":1761563926941,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.carrev.2023.08.008","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T05:17:24Z","timestamp":1692940644000},"page":"43-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Editorial: STOP or YIELD sign at the intersection of TAVR and amyloidosis?"],"prefix":"10.1016","volume":"58","author":[{"given":"Rony N.","family":"Lahoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Abadie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2023.08.008_bb0005","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2023.08.008_bb0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12968-017-0415-x","article-title":"Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis","volume":"19","author":"Cavalcante","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.carrev.2023.08.008_bb0015","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005066","article-title":"Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement","volume":"9","author":"Treibel","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2023.08.008_bb0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jcmg.2020.07.011","article-title":"Prognostic significance of cardiac amyloidosis in patients with aortic stenosis: a systematic review and meta-analysis","volume":"14","author":"Ricci","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2023.08.008_bb0025","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1002\/ehf2.13876","article-title":"Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis","volume":"9","author":"Cannata","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.carrev.2023.08.008_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014115","article-title":"Reverse remodeling following valve replacement in coexisting aortic stenosis and transthyretin cardiac amyloidosis","volume":"15","author":"Nitsche","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2023.08.008_bb0035","article-title":"Outcomes of transcatheter aortic valve replacement in patients with and without amyloidosis: a nationwide analysis from the United States","author":"Ismayl","year":"2023","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2023.08.008_bb0040","article-title":"Outcomes of transcatheter aortic valve replacement in patients with coexisiting amyloidosis","volume":"2","author":"Elzeneini","year":"2023","journal-title":"JACC: Advances"},{"key":"10.1016\/j.carrev.2023.08.008_bb0045","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/ehjci\/jeac146","article-title":"Echocardiographic predictors of presence of cardiac amyloidosis in aortic stenosis","volume":"23","author":"Jaiswal","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2023.08.008_bb0050","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2023.08.008_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.14797\/mdcvj.1050","article-title":"Cardiac amyloidosis treatment","volume":"18","author":"Stern","year":"2022","journal-title":"Methodist Debakey Cardiovasc J"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838923007911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838923007911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:27:58Z","timestamp":1761560878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838923007911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":11,"alternative-id":["S1553838923007911"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2023.08.008","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial: STOP or YIELD sign at the intersection of TAVR and amyloidosis?","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2023.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}